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Hypoderma tarandi causes myiasis in reindeer and 
caribou (Rangifer tarandus spp.) in most northern 
hemisphere regions where these animals live. We 
report a series of 39 human myiasis cases caused by 
H. tarandi in Norway from 2011 to 2016. Thirty-two 
were residents of Finnmark, the northernmost county 
of Norway, one a visitor to Finnmark, and six lived in 
other counties of Norway where reindeer live. Clinical 
manifestations involved migratory dermal swellings 
of the face and head, enlargement of regional lymph 
nodes, and periorbital oedema, with or without eosin-
ophilia. Most cases of human myiasis are seen in tropi-
cal and subtropical countries, and in tourists returning 
from such areas. Our findings demonstrate that myia-
sis caused by H. tarandi is more common than previ-
ously thought. Healthcare professionals in regions 
where there is a likelihood of human infestation with 
H. tarandi (regions populated by reindeer), or treat-
ing returning travellers, should be aware of the con-
dition. All clinicians are advised to obtain a detailed 
travel history when assessing patients with migratory 
dermal swellings. On clinical suspicion, ivermectin 
should be given to prevent larval invasion of the eye 
(ophthalmomyiasis). Since H. tarandi oviposits on hair, 
we suggest wearing a hat as a prevention measure.
Introduction
Myiasis is the condition where fly larvae have infested 
a mammal and feed on its tissues. Cutaneous myiasis 
can be subdivided into furuncular, migratory (creep-
ing) and wound myiasis [1,2]. Cutaneous myiasis, the 
most common form in humans, is endemic in poor 
populations of many tropical and subtropical countries 
[3,4]. In Europe, myiasis is a relatively common travel-
associated skin condition [1,2]. Migratory myiasis in 
humans is caused by Gasterophilus and Hypoderma 
flies (order Diptera, family Oestridae) [5]. Hypoderma 
tarandi causes myiasis in reindeer and caribou in most 
northern hemisphere regions (Alaska, Canada, Nordic 
countries in Europe including Greenland (self-govern-
ing territory of Denmark) and Russia) where these ani-
mals live [5].
Most of the 24 human cases of myiasis caused by H. 
tarandi reported in Norway and other countries in the 
literature from 1982 to 2016 [6-17] developed oph-
thalmomyiasis interna (OMI), a condition where the 
larva has invaded the eye globe, often leading to vis-
ual impairment. Most of them were visitors to north-
ern parts of Norway and Sweden. Two cases were 
from Nunavut (northern Canada) [13] and one from 
Greenland [17]. Here we present clinical and epidemi-
ological features from a large case series of an addi-
tional 39 consecutive human cases of myiasis caused 
by H. tarandi, mostly in children in northern Norway, 
from 2011 to 2016.
Methods
Recruitment of cases and setting
Patients with suspected myiasis (transitional dermal 
swellings of the face or head, history of residence in or 
visit to a reindeer-inhabited area in summer or autumn) 
were recruited from August 2011 to October 2016. 
Most were recruited by the Department of Paediatrics, 
Finnmark Hospital Trust (Hammerfest, Finnmark) and 
by primary care physicians in Finnmark, the remainder 
by primary care physicians in other counties of Norway. 
A blood sample was taken for serological assaying. 
Diagnosis was based on clinical manifestations, serol-
ogy and other findings. Data regarding baseline char-
acteristics (age, sex, occupation, residence and clinical 
history) were collected, and consent to publish case 
details was obtained from each patient. The patients 
were diagnosed and managed consecutively as they 
were recruited.
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After the first three cases were diagnosed in early 
November 2012 (symptom onset September–November 
2012), we sent a letter about H. tarandi myiasis in early 
December 2012 to inform primary care physicians in 
Finnmark, and the Departments of Paediatrics and 
Ophthalmology at the University Hospital of North 
Norway (UNN), Trømsø. News media, such as NRK 
Sápmi (a Sami-language television broadcasting ser-
vice for Norway, Finland and Sweden), promoted infor-
mation about the disease in December 2012. Other 
news media in Norway, Finland and Sweden also 
informed the public in 2013, and authors of this paper 
and others described the condition at medical meet-
ings (Norway and Sweden) and reindeer husbandry 
conferences (Norway and Finland). One of the adult 
cases, who visited Finnmark to hunt in August 2012, 
was from a county in southern Norway where there are 
no reindeer (symptom onset September 2012, sought 
medical attention after receiving information via 
media). Similarly, two children in Finnmark, with myia-
sis symptom onset in September and November 2011, 
respectively, received information via media, and were 
shown to be seropositive and diagnosed more than a 
year after symptom onset.
Laboratory testing
Serum was assayed (ELISA) for antibodies (IgG) 
against Hypodermin C (HyC, a collagenolytic enzyme 
secreted by Hypoderma spp. larvae during migration in 
the host), essentially as described for sera from rein-
deer [18]. Briefly, 96-well microtitre plate wells (Nunc 
PolySorp, Nunc, Roskilde, Denmark) were coated (0.5 
µg/ml of HyC in 0.1 M sodium carbonate buffer, pH 9.6, 
1 hour at 37 °C) and blocked (5% skimmed milk powder 
(Merck KGaA, Darmstadt, Germany) in washing buffer 
(0.05 M Tris-HCL, pH 7.4, containing 150 mM NaCl and 
1% Triton X-100), 30 min at 37 °C). Following this, the 
wells were incubated (30 min, 37 °C) with test sam-
ples serially twofold diluted (1:50–1:6.400) in washing 
buffer. Antibodies were detected using horseradish 
peroxidase (HRP)-conjugated rabbit anti-human IgG 
(DAKO, Glostrup, Denmark). The wells were washed x4 
between each incubation step. O-phenylenediamine 
(OPD, Dako) served as substrate. Colour development 
was stopped (1M H2SO4, after 30 min) and read as 
OD at 492 nm (OD492). The positive control used was 
serum from a 10-year-old child who had had a H. tarandi 
larva removed from an eye [16] (collected in December 
after the summer of infestation). The negative control 
used was serum from a 50-year-old adult with no his-
tory of H. tarandi infestation. The controls were run in 
every plate. Each OD492-reading was expressed as an 
ELISA percentage relative to the 1/50-dilution reading 
for the positive (100%) and the negative (0%) control 
[19]. Identification of seropositives was by comparison 
with the corresponding negative-control dilution series 
in the same plate. Five additional sera from adults with 
no history of H. tarandi myiasis were assayed, and the 
dilution curves (1:50–1:6.400) for all were practically 
identical to the negative control curve. Each of the neg-
ative control dilutions gave an ELISA percentage within 
the range 5 to minus 5 and followed the negative con-
trol graph (Figure 1).
Seropositivity or seronegativity was identified by com-
parison with the dilution curve for the negative control. 
For test sera, if the 1/50-dilution ELISA percentage was 
in the 10–30% range, the serum was considered sus-
pect, and seropositivity was confirmed or disproved 
Figure 1
Serum samples from an 8-year-old child with myiasis 








































Symptom onset: October 2013. Serum samples assayed (ELISA) 
for antibodies (IgG) against Hypodermin C. First sample (October 
2013) giving suspicion of myiasis, second sample (14 days later in 
November 2013) confirming seropositivity.
Figure 2
Myiasis cases caused by Hypoderma tarandi, by year, 



















The children ranged in age from 3 to 12 years, and the adults from 
20 to 66 years. 2011 cases were diagnosed retrospectively in 2013.
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by a new sample collected ≥ 2 weeks after the first. 
Seropositive samples gave ELISA percentages higher 
than the corresponding negative control dilution per-
centage, at dilutions of up to 1/1.600–1/3.200 or 
higher.
Determination of larva and egg remnants
Larva identification was by morphology of cuticular 
spikes and mouthparts [10]. Egg remnants were identi-
fied by comparison with H. tarandi eggs.
Results
The study included 39 persons from Norway seek-
ing medical help for clinical symptoms compatible 
with H. tarandi myiasis from August 2011 to October 
2016 (Figure 2). All had dermal swellings and all were 
seropositive.
Thirty-two cases were children (age range: 3–12 years, 
mean ± standard deviation (SD): 7.6 ± 2.4 years, 13/32 
girls) and seven were adults (age range: 20–66 years; 
mean ± SD: 46.3 ± 16.8 years; 3/7 women). Thirty-two 
were resident in Finnmark. One of the adults, a traveller 
to Finnmark for hunting (August 2012, symptom onset 
September 2012), was seropositive by the first sample 
assayed (serum collected February 2013). Two children, 
with symptom onset in September and November 2011, 
respectively, were found to be seropositive by samples 
collected in February and January 2013, respectively. 
These three persons all sought medical help for their 
symptoms after receiving information via news media. 
One of the children had a dermal swelling on presenta-
tion (incised with no finding of larva) and was given 
one dose of ivermectin [15]. One child no longer had 
symptoms on presentation and received no treatment. 
Of the 39 cases, 17 were infested in 2012, 15 of the 17 in 
Finnmark. Aside from the myiasis symptoms, all cases 
presented with good general health.
Table 1 summarises the clinical characteristics. Figure 
3 shows the time of symptom onset for 35 of the 39 
cases.
In 35 of the 39 cases, seropositivity was confirmed by 
the serum collected at the first medical evaluation. In 
four cases, the serology result for the first serum sam-
ple (collected in August in one case, in October in three 
cases) was suspect, and seropositivity was confirmed 
by a new sample collected ≥ 2 weeks after the first. 
Another three cases had symptoms during autumn/
winter, and serum collected at the first medical evalu-
ation (in February, May and June, respectively) con-
firmed seropositivity.
Eight of the 39 cases were members of reindeer-hus-
bandry families. Only one of the 39 (adult, seeking 
medical help in early July 2016) had noticed any con-
tact with a bumble-bee-sized insect compatible with H. 
tarandi that could be associated with the infestation. 
This person observed a fly in their hair, and recognised 
it as H. tarandi, while ear-tagging reindeer calves in 
late June.
Dermal swellings (Figure 4a) were often migratory. 
Periorbital oedema (uni- or bilateral) (Figure 4b), in 
connection with dermal swellings, was commonly 
observed, and in a few cases was observed as a gen-
eral oedema of the forehead.
There was no apparent correlation between eosino-
philia and severity of symptoms among the cases with 
eosinophilia (Table 1).
Three children had facial dermal swellings, each with 
a dark spot, suspected to be the larval breathing hole. 
For two of them, no larva or remnants thereof were 
found by incision of the swellings. From the third, a 
1.5 mm-long live larva (Figure 5a) was extracted from a 
temple region swelling in mid-November.
The larva was identified as a second instar (L2, see 
Discussion) larva of H. tarandi. From another patient, 
egg remnants (Figure 5b) were found attached to scalp 
hairs in mid-September. The remnants were identified 
as being from H. tarandi eggs. The first 10 cases diag-
nosed in 2012 were referred to an ophthalmologist, 
who demonstrated no ocular complications (personal 
communication, Kristian Fossen, January 2013).
Discussion
This report presents, to our knowledge, the largest 
case series of myiasis diagnosed in one geographic 
area of Europe. We assume that the information about 
H. tarandi myiasis that was broadcast through media 
Figure 3
Month of symptom onset for myiasis cases caused by 
































Symptom onset information not available for four cases.
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and conference presentations from late 2012 to 2013 
reached a large audience in the Nordic countries. In 
agreement with this assumption, the visitor from a 
southern Norwegian county to Finnmark for hunting 
in August 2012, sought medical help after receiving 
information via the media. Similarly, two children with 
symptom onset in September and November 2011, 
respectively, were diagnosed after their families had 
received information via the media, more than a year 
after symptom onset. Our serological assaying for H. 
tarandi myiasis was established in association with a 
case in Sweden in 2009 [20], and today there is still 
no other option for serological assaying for the condi-
tion in the Nordic countries. We therefore believe that 
we received blood samples from all suspected cases in 
2011–2016, and that the 39 cases reported here make 
up the complete list of diagnosed cases in Norway in 
the period.
Most cases were residents of Finnmark, a county where 
the number of reindeer was 183,600 in 2012 [21], ca 2.5 
times the number of humans. Ivermectin is regularly 
used in reindeer, targeting H. tarandi and other para-
sites, mostly to help the individual animal through the 
harsh arctic winter. Particularly in Finland, ivermectin 
has been used regularly since it came on the commer-
cial market in the early 1980s. The long-term use of 
the drug does not seem to have reduced the H. tarandi 
population or the infestation problem in reindeer. In 
reindeer calves in Finland, the annual infestation level 
is up to 100% in the northernmost part of the reindeer-
husbandry area [22]. Likewise, examination of 1,305 
hides from slaughtered reindeer in Finnmark in 1984–
1985 demonstrated H. tarandi larvae in 99.9% [23], and 
there is no indication of reduced infestation level in 
reindeer in Finnmark after that time. With such a high 
infestation level, it would be difficult to know whether 
the infestation level in reindeer was even higher in 
2012 and 2013. It is a core assumption of parasite pop-
ulation dynamics that there is a positive relationship 
between parasite transmission rate and host popula-
tion density [24]. Because Finnmark has a higher num-
ber of reindeer per inhabitant than any other region of 
Scandinavia and Finland, a higher frequency of human 
infestations could possibly be expected. There could, 
however, be other factors contributing to the higher 
number in Finnmark compared with other regions of 
Norway, such as differences related to weather and 
climate. Most cases were children, in common with 
reports of myiasis from other parts of the world [3,4], 
and we could speculate that differences such as immu-
nity, skin thickness and behaviour between children 
and adults are possible affecting factors.
The cases presented with a uniform clinical picture 
involving enlarged occipital and retroauricular lymph 
nodes and dermal swellings located on the head 
and face, with symptom onset most often occur-
ring between September and December. The main H. 
tarandi oviposition period is from July to August [25], 
and two cases with symptom onset in July clearly illus-
trate a risk of infestation as early as June. All 39 cases 
had dermal swellings. A large proportion of OMI in pre-
viously reported cases [6-17], along with the absence 
in most of these cases of reporting of dermal swellings, 
suggest that clinicians, including ophthalmologists in 
many cases, may have overlooked this important symp-
tom. Consequently, patients’ delay in seeking medical 
help, and doctors’ delay in diagnosis, may have led 
to severe eye complications. The dermal swellings 
resolved spontaneously in two cases, indicating that 
Figure 4
Dermal swellings in two cases infested with Hypoderma 
tarandi, Norway, October to November 2012
A. Forehead of a 12-year-old child  
B. Periorbital oedema in a 6-year-old child  
4B: The oedema became bilateral one week later.
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the condition can be self-limiting. This was indirectly 
confirmed by primary care physicians in Finnmark, 
who told us in interviews that dermal swellings and 
lymphadenopathy had occasionally been observed 
over the years and were considered to be a condition 
of unknown origin, associated with autumn, that could 
heal spontaneously.
Ivermectin is the drug of choice in treatment of oncho-
cerciasis (river blindness), strongyloidiasis, cutaneous 
larva migrans and other conditions caused by para-
sites [26]. The drug is generally well tolerated, as also 
demonstrated by our results. It has some protective 
effect on visual field loss and optic nerve disease in 
river blindness [27]. However, severe adverse effects 
are infrequently seen in river blindness treatment when 
substantial amounts of microfilariae are present, and 
serious post-treatment reactions, characterised by 
hypotension, pruritic rash, lymphadenopathy, arthral-
gia and malaise, was associated with treatment of river 
blindness especially in patients co-infected with the 
filarial nematode Loa loa [26,28,29]. There has been 
some uncertainty regarding the safety of ivermectin 
in the presence of ocular symptoms due to the possi-
ble risk of local inflammatory reaction [13]. Ivermectin 
given in a case of OMI resulted in visual improvement, 
with no serious side-effects noted [30].
The live larva extracted from a dermal swelling of a 
child was identified as a second instar (L2) larva. The 
larva of H. tarandi has three developmental stages 
(L1-L3). L2 encysts in a nodule under the skin, with a 
breathing hole to the outside, where it develops to L3, 
the stage where it leaves the host through the breath-
ing hole [5]. The dark spot on top of the dermal swell-
ing, suspected to be the larva breathing hole, indicated 
stage L2 [31], as did the size and morphology of the 
larva. Development to H. tarandi L2 in a human has 
not, to our knowledge, been reported before. H. tarandi 
eggs in the hair, and egg remnants as demonstrated in 
one case here, are easily distinguished from head lice 
eggs [20].
Of the 39 cases, 31 were not members of reindeer 
husbandry families or in other potentially close con-
tact with reindeer. For the Sami people, an indigenous 
population in Norway, Sweden, Finland and the Kola 
peninsula of Russia, reindeer husbandry is an impor-
tant part of their way of life. There is no indication that 
Sami have any raised awareness of the risk of human 
infestation by H. tarandi (data not shown). Since H. 
tarandi oviposits on hair, the prevention measure we 
suggest to avoid infestation is to wear a hat or similar, 
and indeed, Sami people have a long tradition of cover-
ing their hair when outdoors.
Until recently, human myiasis caused by H. tarandi was 
largely unknown to physicians and general public in 
the Nordic countries. Knowledge of a recently reported 
case in Sweden [20] was important for the diagnosis of 
the first cases in Finnmark in 2012. These cases drew 
the immediate attention of mass media in Norway, 
Sweden and Finland. Although Sweden and Finland 
have high numbers of reindeer, we are not aware of any 
reported human case in Finland, or any new case in 
Sweden since 2011. A case in Greenland was reported 
in early 2016 [17]. The diagnosis of the many cases in 
2012 and 2013 could partly be due to increased aware-
ness of the condition after the recent reporting of cases 
from Sweden [15,20]. It is not likely that the many diag-
noses were due to the publicity in the media and the 
letter to physicians about H. tarandi myiasis, since the 
publicity and the letter came after the first three cases 
were diagnosed in early November 2012. Furthermore, 
Figure 5
Larva and egg remnants in two cases infested with 
Hypoderma tarandi, Norway, September and November 
2012
A. 1.5 mm-long live Hypoderma tarandi larva extracted from a 
temple region dermal swelling of a 6-year-old child, identified as a 
second instar (L2)
B. H. tarandi egg remnants found attached to a hair of a 4-year-old 
child
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since there were so many cases diagnosed over a short 
time (infestation season 2012; 12/17 diagnosed in 
November–December 2012, 5/17 in January–June 2013, 
data not shown), we consider the cases after the infes-
tation season 2012 to be an outbreak, possibly caused 
by weather and climate conditions or other factors. 
Such factors could also possibly contribute to explain-
ing the apparent difference in prevalence of myiasis 
caused by H. tarandi between countries and regions, 
such as between Finland and northern Norway. This 
issue, and the apparent difference in prevalence 
between children and adults, is beyond the scope of 
this study and awaits further evaluation.
In western and southern European countries and in 
North America, most cases of myiasis are seen in 
travellers returning from sub-Saharan Africa, Central 
and South America [3,4]. The aetiology of myiasis in 
patients with no history of recent travel to a tropical 
or subtropical country can be a diagnostic problem [3]. 
In addition, migratory myiasis is considered more dif-
ficult to diagnose compared with the furuncular myia-
sis because of the absence of a breathing hole [31]. 
Healthcare professionals, in regions where humans 
have a likelihood of being infested with H. tarandi, and 
those meeting travellers returning from such regions, 
should be aware of the condition, and they are advised 
to obtain a detailed travel history when assessing 
patients with migratory dermal swellings.
Conclusion
The diagnosis of myiasis in patients with no history of 
recent travel to a tropical or subtropical country can 
be a diagnostic problem. Myiasis caused by H. tarandi 
is more common than previously thought, at least in 
Norway, but the prevention measure is simply to cover 
the hair with a cap or similar. The condition presents 
a uniform clinical picture that should be recognised 
by physicians in areas populated by reindeer and 
those meeting travellers returning from such regions. 
Ivermectin should be given on clinical suspicion. If 
symptoms persist after the first dose, the treatment 
should be repeated. Serological confirmation is rec-
ommended when possible. Only patients with ocular 
symptoms should be referred to an ophthalmologist.
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